Regeneron Pharmaceuticals, Inc. Income Statement

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Dec2009	Dec2010	Dec2011	Dec2012	Dec2013	Dec2014	Dec2015	Dec2016	Dec2017	Dec2018	Dec2019	Dec2020	Dec2021	Dec2022	Dec2023	Dec2024
Revenue & cost
Revenue	0.38B	0.46B	0.45B	1.38B	2.10B	2.82B	4.10B	4.86B	5.87B	5.15B	6.56B	8.50B	16.07B	12.17B	13.12B	14.20B
Cost of Revenue	0.00B	0.00B	0.00B	0.08B	0.12B	0.13B	0.24B	0.19B	0.20B	0.24B	0.40B	0.63B	1.77B	0.80B	0.93B	1.09B
Gross Profit	0.38B	0.46B	0.44B	1.29B	1.99B	2.69B	3.86B	4.67B	5.67B	4.91B	6.15B	7.87B	14.30B	11.37B	12.19B	13.11B
Operating items
Research & Development	0.40B	0.49B	0.53B	0.63B	0.86B	1.27B	1.62B	2.05B	2.08B	1.47B	2.45B	2.65B	2.86B	3.59B	4.44B	5.13B
Selling, General & Administrative	0.05B	0.07B	0.12B	0.21B	0.35B	0.52B	0.84B	1.18B	1.32B	1.13B	1.34B	1.35B	1.82B	2.12B	2.63B	2.95B
Other Operating Expenses	0.00B	0.00B	0.00B	0.08B	0.16B	0.21B	0.39B	0.30B	0.40B	0.40B	0.21B	0.28B	0.05B	0.09B	0.00B	-0.05B
Operating Expenses	0.45B	0.56B	0.65B	0.92B	1.36B	2.00B	2.85B	3.53B	3.79B	2.61B	4.35B	4.92B	7.12B	7.43B	9.07B	10.21B
Operating Income	-0.07B	-0.10B	-0.21B	0.46B	0.74B	0.82B	1.25B	1.33B	2.08B	2.53B	2.21B	3.58B	8.95B	4.74B	4.05B	3.99B
EBIT	-0.07B	-0.10B	-0.21B	0.46B	0.74B	0.82B	1.25B	1.33B	2.08B	2.53B	2.21B	3.58B	8.95B	4.74B	4.05B	3.99B
Non-operating items
Interest & Investment Income	0.00B	0.00B	0.00B	0.00B	-0.00B	-0.04B	-0.01B	-0.01B	-0.03B
Other Non Operating Income				0.00B	-0.00B	-0.03B	-0.01B	0.01B	0.02B	0.05B	0.25B	0.29B	0.44B	0.18B	0.23B	0.84B
Non Operating Income	0.00B	-0.01B	-0.02B	-0.04B	-0.05B	-0.06B	-0.03B	0.01B	0.02B	0.05B	0.25B	0.29B	0.44B	0.18B	0.23B	0.84B
Net income details
EBT	-0.07B	-0.10B	-0.22B	0.41B	0.70B	0.76B	1.23B	1.33B	2.08B	2.55B	2.43B	3.81B	9.33B	4.86B	4.20B	4.78B
Tax Provisions	-0.00B		-0.00B	-0.34B	0.28B	0.42B	0.59B	0.43B	0.88B	0.11B	0.31B	0.30B	1.25B	0.52B	0.25B	0.37B
Profit After Tax	-0.07B	-0.10B	-0.22B	0.75B	0.41B	0.34B	0.64B	0.90B	1.20B	2.44B	2.12B	3.51B	8.08B	4.34B	3.95B	4.41B
Income from Continuing Operations	-0.07B	-0.10B	-0.22B	0.75B	0.41B	0.34B	0.64B	0.90B	1.20B	2.44B	2.12B	3.51B	8.08B	4.34B	3.95B	4.41B
Consolidated Net Income	-0.07B	-0.10B	-0.22B	0.75B	0.41B	0.34B	0.64B	0.90B	1.20B	2.44B	2.12B	3.51B	8.08B	4.34B	3.95B	4.41B
Income towards Parent Company	-0.07B	-0.10B	-0.22B	0.75B	0.41B	0.34B	0.64B	0.90B	1.20B	2.44B	2.12B	3.51B	8.08B	4.34B	3.95B	4.41B
Net Income towards Common Stockholders	-0.07B	-0.10B	-0.22B	0.75B	0.41B	0.34B	0.64B	0.90B	1.20B	2.44B	2.12B	3.51B	8.08B	4.34B	3.95B	4.41B
Additional items
EPS (Basic)	-0.00B	-0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
EPS (Weighted Average and Diluted)		-0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Shares Outstanding (Weighted Average)	0.08B	0.08B	0.09B	0.10B	0.10B	0.10B	0.10B	0.11B	0.11B	0.11B	0.11B	0.11B	0.11B	0.11B	0.11B	0.11B
Shares Outstanding (Diluted Average)		0.08B	0.09B	0.12B	0.11B	0.11B	0.12B	0.12B	0.12B	0.11B	0.11B	0.12B	0.11B	0.11B	0.11B	0.12B
EBITDA	-0.07B	-0.11B	-0.22B	0.75B	0.41B	0.39B	0.59B	0.87B	1.21B	2.44B	2.15B	3.52B	8.02B	4.13B	4.11B	4.49B
Tax Rate	5.73%		0.51%		40.59%	55.58%	48.08%	32.66%	42.34%	4.27%	12.90%	7.80%	13.41%	10.71%	5.85%	7.68%

Regeneron Pharmaceuticals, Inc. Income Statement

Create an account

Sign In

Reset Password

Get Pro for 60% off